DK0598899T3 - Væskefasesyntese af peptider og peptidderivater - Google Patents

Væskefasesyntese af peptider og peptidderivater

Info

Publication number: DK0598899T3
Authority: DK; Denmark
Prior art keywords: peptides; liquid phase; peptide derivatives; phase synthesis; protecting group
Prior art date: 1992-06-16

Application number

DK93916581T

Other languages

Danish (da)

English (en)

Inventor

Gary A Siwruck

John S Eynon

Original Assignee

Kinerton Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-06-16

Filing date

1993-06-16

Publication date

1999-02-08

1993-06-16 Application filed by Kinerton Ltd filed Critical Kinerton Ltd

1999-02-08 Application granted granted Critical

1999-02-08 Publication of DK0598899T3 publication Critical patent/DK0598899T3/da

Links

108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
230000015572 biosynthetic process Effects 0.000 title abstract 2
239000007791 liquid phase Substances 0.000 title abstract 2
102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
238000003786 synthesis reaction Methods 0.000 title abstract 2
125000003088 (fluoren-9-ylmethoxy)carbonyl group Chemical group 0.000 abstract 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 abstract 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
125000006239 protecting group Chemical group 0.000 abstract 2
229910021529 ammonia Inorganic materials 0.000 abstract 1
150000001718 carbodiimides Chemical class 0.000 abstract 1
239000007822 coupling agent Substances 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1
125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 abstract 1
238000010189 synthetic method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/064—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for omega-amino or -guanidino functions
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Life Sciences & Earth Sciences (AREA)
Analytical Chemistry (AREA)
Peptides Or Proteins (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK93916581T 1992-06-16 1993-06-16 Væskefasesyntese af peptider og peptidderivater DK0598899T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IE194292A IE921942A1 (en)	1992-06-16	1992-06-16	Liquid phase synthesis of peptides and peptide derivatives
PCT/US1993/005783 WO1993025571A1 (fr)	1992-06-16	1993-06-16	Synthese en phase liquide de peptides et de derives de peptides

Publications (1)

Publication Number	Publication Date
DK0598899T3 true DK0598899T3 (da)	1999-02-08

Family

ID=11039683

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK93916581T DK0598899T3 (da)	1992-06-16	1993-06-16	Væskefasesyntese af peptider og peptidderivater

Country Status (11)

Country	Link
EP (1)	EP0598899B1 (fr)
JP (1)	JPH06509821A (fr)
AT (1)	ATE171708T1 (fr)
AU (1)	AU671660B2 (fr)
CA (1)	CA2115668A1 (fr)
DE (1)	DE69321324T2 (fr)
DK (1)	DK0598899T3 (fr)
ES (1)	ES2123059T3 (fr)
IE (1)	IE921942A1 (fr)
NZ (1)	NZ254389A (fr)
WO (1)	WO1993025571A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5587507A (en) *	1995-03-31	1996-12-24	Rutgers, The State University	Synthesis of tyrosine derived diphenol monomers
USRE37160E1 (en) *	1990-06-12	2001-05-01	Rutgers, The State University	Synthesis of tyrosine derived diphenol monomers
US5874532A (en) *	1997-01-08	1999-02-23	Nexstar Pharmaceuticals, Inc.	Method for solution phase synthesis of oligonucleotides and peptides
DE602004009710T2 (de)	2003-12-31	2008-08-07	F. Hoffmann-La Roche Ag	Verfahren zur peptidsynthese unter verwendung einer reduzierten menge an entschützungsmittel
EP1701976A2 (fr) *	2003-12-31	2006-09-20	F.Hoffmann-La Roche Ag	Synthese de peptides et deprotection a l'aide d'un co-solvant
WO2007099656A1 (fr) *	2006-03-01	2007-09-07	Kaneka Corporation	Procede de production d'un peptide
JP5212371B2 (ja) *	2007-07-25	2013-06-19	味の素株式会社	ペプチドの製造方法
EP2976331B1 (fr)	2013-03-21	2017-03-01	Sanofi-Aventis Deutschland GmbH	Synthèse de produits peptidiques contenant de l'hydantoïne
DK2976325T3 (en)	2013-03-21	2017-06-06	Sanofi Aventis Deutschland	SYNTHESIS OF PEPTIDE PRODUCTS CONTAINING CYCLIC IMID
ES2864924T3 (es) *	2015-03-04	2021-10-14	Jitsubo Co Ltd	Método de síntesis peptídica
US10947267B2 (en)	2015-12-21	2021-03-16	Texas Tech University System	System and method for solution phase gap peptide synthesis
KR101791526B1 (ko) *	2016-02-18	2017-11-01	(주)케어젠	발모 촉진 활성을 나타내는 펩타이드 및 이의 용도
EP3802554B1 (fr) *	2018-05-31	2023-12-13	Sederma	Procédé de synthèse peptidique en phase solution et stratégies de protection associées
US12024537B2 (en)	2018-05-31	2024-07-02	Sederma	Compositions and methods for chemical synthesis
US11827660B2 (en)	2019-02-01	2023-11-28	Sederma	Synthesis strategy for gap protecting group

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3121707A (en) *	1960-11-23	1964-02-18	American Cyanamid Co	Peptide synthesis using n-n' carbonyldiimidazole activator
US3769271A (en) *	1971-04-15	1973-10-30	Lilly Co Eli	N-protected amino acids and peptides
US4581168A (en) *	1983-02-21	1986-04-08	Sanofi	Synthesis of hpGRF (Somatocrinin) in liquid phase and intermediate peptides
US4859736A (en) *	1987-03-30	1989-08-22	Ciba-Geigy Corporation	Synthetic polystyrene resin and its use in solid phase peptide synthesis

1992
- 1992-06-16 IE IE194292A patent/IE921942A1/en not_active Application Discontinuation
1993
- 1993-06-16 WO PCT/US1993/005783 patent/WO1993025571A1/fr active IP Right Grant
- 1993-06-16 DK DK93916581T patent/DK0598899T3/da active
- 1993-06-16 CA CA002115668A patent/CA2115668A1/fr not_active Abandoned
- 1993-06-16 AU AU46381/93A patent/AU671660B2/en not_active Ceased
- 1993-06-16 AT AT93916581T patent/ATE171708T1/de not_active IP Right Cessation
- 1993-06-16 EP EP93916581A patent/EP0598899B1/fr not_active Expired - Lifetime
- 1993-06-16 NZ NZ254389A patent/NZ254389A/en unknown
- 1993-06-16 JP JP6501810A patent/JPH06509821A/ja active Pending
- 1993-06-16 ES ES93916581T patent/ES2123059T3/es not_active Expired - Lifetime
- 1993-06-16 DE DE69321324T patent/DE69321324T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0598899B1 (fr)	1998-09-30
DE69321324D1 (de)	1998-11-05
EP0598899A4 (en)	1995-08-16
AU4638193A (en)	1994-01-04
EP0598899A1 (fr)	1994-06-01
JPH06509821A (ja)	1994-11-02
WO1993025571A1 (fr)	1993-12-23
ES2123059T3 (es)	1999-01-01
DE69321324T2 (de)	1999-03-11
ATE171708T1 (de)	1998-10-15
AU671660B2 (en)	1996-09-05
IE921942A1 (en)	1993-12-29
NZ254389A (en)	1996-03-26
CA2115668A1 (fr)	1993-12-23

Similar Documents

Publication	Publication Date	Title
DK0598899T3 (da)	1999-02-08	Væskefasesyntese af peptider og peptidderivater
MX9301457A (es)	1994-02-28	Agentes antifungicos de peptidos ciclicos y proceso para su preparacion.
SE9301911D0 (sv)	1993-06-03	New peptide derivatives
PT89961A (pt)	1989-11-10	Processo para a preparacao de n-carboxianidridos de aminoacidos protegidos por uretano
NO975729L (no)	1998-02-05	Forbindelser og peptider som binder til etytropoietinreseptoren
DK0623144T3 (da)	2002-05-13	Syntetiske peptider til detoksificering af bakterielle endotoksiner og behandling af septisk shock
BR9408087A (pt)	1998-07-14	Recuperação de um aminoácido
DK0463450T3 (da)	1994-06-27	Vasoaktive intestinale polypeptid-analoger og udnyttelsen heraf
DK0538754T3 (da)	1998-03-30	Anvendelse af antistofholdige præparater til immunundertrykkelse
PT83535B (pt)	1989-05-31	Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos
EP0123950A3 (fr)	1986-12-30	Intermédiaires pour la thymosine alpha 1 et pour la désacéthylthymosine alpha 1
DK0437563T3 (da)	1995-05-29	Bioligiske aktive lægemiddelpolymerderivater
NO983691L (no)	1998-08-12	Forbindelser tilh°rende amidiniumfamilien, farmas°ytiske preparater inneholdende disse samt anvendelse derav
ES2137620T3 (es)	1999-12-16	Ligandos peptidicos para la region constante de las inmunoglobulinas.
DK0463053T3 (da)	1998-10-07	Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
FI963864L (fi)	1996-09-27	Parannettu menetelmä 6,9-bis((2-aminoetyyli)amino)bentso(g)-isokinoliini-5,10-dionin ja sen dimaleaattisuolan syntetisoimiseksi
ATE45165T1 (de)	1989-08-15	Reduzierte peptide, hemmungsstoffe gastrischer ausscheidung, verfahren zur herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE93527T1 (de)	1993-09-15	Peptide und deren benutzung.
SG64917A1 (en)	1999-05-25	Method of peptide synthesis and new synthesis intermediates
CA1264899C (fr)	1990-01-23	Synthese de peptides a l'aide de dioxydes de thioxanthylmethyloxycarbonyle
BR9815448A (pt)	2001-10-16	Derivados de imino-aza-antraciclinona para o tratamento de amiloidose
PT83837B (pt)	1989-07-31	Processo para a preparacao de peptideos por utilizacao de percloratos
DK0661328T3 (da)	2000-07-03	Hidtil ukendte epoxid-amin-addukter som hærdere til vandige epoxidsystemer
JPS6416792A (en)	1989-01-20	Guanidine related compound containing tetraphenylborate ion, its production and use thereof in peptide synthesis
NO910664L (no)	1991-08-21	Fremgangsmaate ved fremstilling av lh-rh-analoger med temporaer og minimal beskyttelse.